BioStock: Lipum on the financial statement and BIO-Europe

Biopharma company Lipum has published its year-end report for 2022 and  recently returned from BIO-Europe. The company's CEO Einar Pontén and Chairman of the Board Ulf Björklund participated to meet potential partners and present the progress in the clinical study with the drug candidate SOL-116. BioStock had a chat with Lipum's CEO.

Read the interview with Lipum's CEO Einar Pontén at biostock.se:

https://www.biostock.se/en/2023/03/lipum-on-the-financial-statement-and-bio-europe/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/